Skip to content

Gen-Probe

Country not established

Devices
64
FDA recalls
6

What Gen-Probe makes

Gen-Probe develops molecular diagnostic tests for infectious disease detection, including nucleic acid amplification assays for *Chlamydia trachomatis*, *Neisseria gonorrhoeae*, and *Mycoplasma pneumoniae*, as well as culture-based probes for *Mycobacterium tuberculosis*, *Mycobacterium gordonae*, *Haemophilus influenzae*, and *Cryptococcus neoformans*. Their portfolio also includes rapid detection systems for respiratory pathogens and confirmatory assays for gonorrhea.

The company’s diagnostic devices are authorised under US FDA regulations, with most classified as Class I or Class II. Products are listed via the 510(k) and PMA pathways, reflecting their regulatory compliance for in vitro diagnostic use in the United States.

AI-generated from registry data, 26 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue64

Newest first, rows 51-64 of 64

Search and filter all 64 devices
Skip device list

Rows 51-64 of 64

Showing 51-64 of 64

FDA recalls6

Recalls are matched to the firm by name. FDA recall data as of 22 Oct 2026.

FDA recall records list 6 recalls initiated by Gen-Probe, the earliest on 2004-06-11 and the most recent on 2014-04-17. By recorded status: 6 terminated. The reasons filed fall into these groups: labeling or instructions for use, packaging and performance or accuracy. A recall is often a precaution started by the manufacturer, and a count of records is not a verdict on a company.

Generated automatically from FDA recall records, as a summary of the records listed below. It describes what the records state and is not an assessment of this manufacturer.

  • 2014

    • 17 Apr 2014 Z-1793-2014 Class III Terminated Incorrect labeling was used on each pouch of the affected lots of APTIMA Urine Specimen Collection Kits. The outer box of the kits are identified correctly as "APTIMA Urine Collection Kits"; however, the inner pouches are incorrectly labeled as "APTIMA Unisex Swab Collection Kit for Endocervical and Male Urethral Swab Specimens." Distribution: Worldwide Distribution - US Nationwide and the countries of Canada (CA), Denmark (DK), France (FR), Germany (DE), and…
      Full distribution text Worldwide Distribution - US Nationwide and the countries of Canada (CA), Denmark (DK), France (FR), Germany (DE), and the United States (US), Belgium (BE), United Kingdom (GB).
      Submission number: K003395
  • 2008

    • 30 Dec 2008 Z-1436-2011 Unclassified (pre-2012) Terminated This recall has been initiated following the identification of certain assay tubes that do not contain probe reagent. The affected kits may contain a combination of tubes with correct probe amount, partial probe amount and some probe tubes that are empty. Possible false negative results. Distribution: Worldwide Distribution -- USA, including Puerto Rico and countries of Australia, Guatemala, Malaysia, Bahamas, Hong…
      Full distribution text Worldwide Distribution -- USA, including Puerto Rico and countries of Australia, Guatemala, Malaysia, Bahamas, Hong Kong, Mali, Singapore, Bermuda, India, Mexico, South Africa, Canada, Israel, Netherlands, South Korea, Finland, Kuwait, Panama, Thailand, France, Latvia, and Philippines.
      Submission number: K974572
    • 30 Dec 2008 Z-1437-2011 Unclassified (pre-2012) Terminated This recall has been initiated following the identification of certain assay tubes that do not contain probe reagent. The affected kits may contain a combination of tubes with correct probe amount, partial probe amount and some probe tubes that are empty. Possible false negative results. Distribution: Worldwide Distribution -- USA, including Puerto Rico and countries of Australia, Guatemala, Malaysia, Bahamas, Hong…
      Full distribution text Worldwide Distribution -- USA, including Puerto Rico and countries of Australia, Guatemala, Malaysia, Bahamas, Hong Kong, Mali, Singapore, Bermuda, India, Mexico, South Africa, Canada, Israel, Netherlands, South Korea, Finland, Kuwait, Panama, Thailand, France, Latvia, and Philippines.
      Submission number: K921435
    • 30 Dec 2008 Z-1438-2011 Unclassified (pre-2012) Terminated This recall has been initiated following the identification of certain assay tubes that do not contain probe reagent. The affected kits may contain a combination of tubes with correct probe amount, partial probe amount and some probe tubes that are empty. Possible false negative results. Distribution: Worldwide Distribution -- USA, including Puerto Rico and countries of Australia, Guatemala, Malaysia, Bahamas, Hong…
      Full distribution text Worldwide Distribution -- USA, including Puerto Rico and countries of Australia, Guatemala, Malaysia, Bahamas, Hong Kong, Mali, Singapore, Bermuda, India, Mexico, South Africa, Canada, Israel, Netherlands, South Korea, Finland, Kuwait, Panama, Thailand, France, Latvia, and Philippines.
      Submission number: K896493
  • 2007

    • 2 May 2007 Z-0145-2008 Unclassified (pre-2012) Terminated Mispackaging: Kits may contain Haemophilus Influenza probe pouches in addition to Group B Streptococcus probe pouches Distribution: Nationwide: including states of AZ, CA, CO, FL, KY, MD, MO, NC, NJ, TX, and UT Submission number: K974572
  • 2004

    • 11 Jun 2004 Z-1072-04 Unclassified (pre-2012) Terminated Reduced stability